Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study

OBJECTIVE: To assess the retention rate, efficacy, safety, and dosing of perampanel administered to patients with epilepsy during routine clinical care in the retrospective phase IV, PROVE Study (NCT03208660). METHODS: Exposure, efficacy, and safety data were obtained from the medical records of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheless, James, Wechsler, Robert T., Lancman, Marcelo, Aboumatar, Sami, Patten, Anna, Malhotra, Manoj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918328/
https://www.ncbi.nlm.nih.gov/pubmed/33681651
http://dx.doi.org/10.1002/epi4.12445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918328/
https://www.ncbi.nlm.nih.gov/pubmed/33681651
http://dx.doi.org/10.1002/epi4.12445

Ejemplares similares